<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36980155</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Persistent Anosmia and Dysgeusia in Children with SARS-CoV-2 Infection: A Retrospective Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">597</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children10030597</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Olfactory and gustative dysfunctions are two of the most common post-acute sequelae of SARS-CoV-2 infection in children, which can have a negative impact on the routines of children and families. As several children have had COVID-19 since the Omicron variant, it is important to investigate if this increase in infections is reflected in higher olfactory/taste disfunctions. The primary aim of this study was to characterize the presence of olfactory/gustative problems in a cohort of children, its evolution, and its association with risk factors such as COVID-19 variant, hospitalization, presence of olfactory/gustative dysfunction during the acute phase, and vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective analysis of children with microbiologically confirmed SARS-CoV-2 infection evaluated in person at a referral pediatric post-COVID-19 clinic in Rome, Italy. We included children younger than 19 years old, evaluated from the beginning of the pandemic up to October 2022. At specific timepoints, we investigated the presence of olfactory/taste disfunctions and evaluated them according to the SARS-CoV-2 variants circulating at the time of infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1250 children (650 females; 52.0%) with a mean age of 6.77 (&#xb1;4.12) years were included in the study. At 3, 6, 12, and 18 months, 12 (9.6%), 7 (5.6%), 2 (1.6%), and 1 (0.8%) of the children reported anosmia and dysgeusia post-COVID-19 infection, respectively. The presence of anosmia and dysgeusia during the acute phase of infection and being infected with a pre-Omicron variant were found to be significant risk factors for persistent olfactory and gustatory dysfunction during all follow-up periods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">anosmia and dysgeusia symptoms tended to decrease gradually over time, but not all children recovered quickly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1142-6678</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2372-084X</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traini</LastName><ForeName>Daniele Omar</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Catholic University of Rome, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Rocca</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medicine and Surgery, Catholic University of Rome, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5394-8335</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6095-9510</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>65925795</GrantID><Agency>Pfizer (Italy)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">dysgeusia</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>D.B. received a research grant to characterize Long COVID in children from Pfizer. D.B. received a consultation fee for peer-to-peer meetings on the impact of SARS-CoV-2 infection in children.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36980155</ArticleId><ArticleId IdType="pmc">PMC10047825</ArticleId><ArticleId IdType="doi">10.3390/children10030597</ArticleId><ArticleId IdType="pii">children10030597</ArticleId></ArticleIdList><ReferenceList><Reference><Citation> [(accessed on 31 December 2022)]; Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pinto Pereira S., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 28 December 2022)]; Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1.</Citation></Reference><Reference><Citation>Morello R., Martino L., Buonsenso D. Diagnosis and management of post-COVID (Long COVID) in children: A moving target. Curr. Opin. Pediatr. 2023;35:184&#x2013;192. doi: 10.1097/MOP.0000000000001221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000001221</ArticleId><ArticleId IdType="pmc">PMC9994801</ArticleId><ArticleId IdType="pubmed">36660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Martino L., Morello R., De Rose C., Valentini P. Chronic Olfactory Dysfunction in Children with Long COVID: A Retrospective Study. Children. 2022;9:1251. doi: 10.3390/children9081251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9081251</ArticleId><ArticleId IdType="pmc">PMC9406427</ArticleId><ArticleId IdType="pubmed">36010141</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Salles T., Vizcaya D., Pistillo A., Casajust P., Sena A.G., Lai L.Y.H., Prats-Uribe A., Ahmed W.U., Alshammari T.M., Alghoul H., et al. Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience. Pediatrics. 2021;148:e2020042929. doi: 10.1542/peds.2020-042929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-042929</ArticleId><ArticleId IdType="pubmed">34049958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A., Kneen R., Defres S., Sejvar J., Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Parri N., De Rose C., Valentini P. Gemelli-pediatric COVID-19 team. Toward a clinically based classification of disease severity for paediatric COVID-19. Lancet Infect. Dis. 2021;21:22. doi: 10.1016/S1473-3099(20)30396-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30396-0</ArticleId><ArticleId IdType="pmc">PMC7228718</ArticleId><ArticleId IdType="pubmed">32422205</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 28 December 2022)].  Available online:  https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-27-maggio-2022.pdf.</Citation></Reference><Reference><Citation>Buonsenso D., Di Gennaro L., De Rose C., Morello R., D&#x2019;Ilario F., Zampino G., Piazza M., Boner A.L., Iraci C., O&#x2019;Connell S., et al. Long-term outcomes of pediatric infections: From traditional infectious diseases to long COVID. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. The challenge of studying long COVID: An updated review. Pediatr. Infect. Dis. J. 2022;41:424&#x2013;426. doi: 10.1097/INF.0000000000003502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003502</ArticleId><ArticleId IdType="pmc">PMC8997013</ArticleId><ArticleId IdType="pubmed">35213866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Pediatr. 2021;110:914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel C.L., Lap C.R., Buddingh E.P., van Houten M.A., van der Sande L.J., Langereis E.J., Bannier M.A.G.E., Pijnenburg M.W.H., Hashimoto S., Terheggen-Lagro S.W.J. Pediatric long-COVID: An overlooked phenomenon? Pediatr. Pulmonol. 2021;56:2495&#x2013;2502. doi: 10.1002/ppul.25521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E., Olsson-&#xc5;kefeldt S., Hertting O., Herlenius E., Alfven T., Rinder M.R., Rhedin S., Hildenwall H. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Pediatr. 2021;110:2578&#x2013;2580. doi: 10.1111/apa.15999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15999</ArticleId><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P. Sechenov StopCOVID Research Team. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez J.N., Grasa C., Calvo C., L&#xf3;pez-Hortelano M.G. Long-term symptoms of COVID-19 in children. Acta Pediatr. 2021;110:2282&#x2013;2283. doi: 10.1111/apa.15849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15849</ArticleId><ArticleId IdType="pmc">PMC8251185</ArticleId><ArticleId IdType="pubmed">33745209</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D., Crawford N., McNab S., Wurzel D., Steer A., Tosif S. Postacute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc. Health. 2021;5:e22&#x2013;e23. doi: 10.1016/S2352-4642(21)00124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati H., Shahisavandi M., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Barzegar Z., Kabiri M., Zeraatpisheh Z., et al. Long COVID in children and adolescents. World J. Pediatr. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossley C.J., Kavaliunaite E., Harman K., Cook J., Ruiz G., Gupta A. Postacute COVID-19 outcomes in children requiring hospitalisation. Sci. Rep. 2022;12:8208. doi: 10.1038/s41598-022-12415-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12415-x</ArticleId><ArticleId IdType="pmc">PMC9113067</ArticleId><ArticleId IdType="pubmed">35581348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M., Ireland G., Amin-Chowdhury Z., Ramsay M.E., Ladhani S.N. Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: Active, prospective, national surveillance. Clin. Infect. Dis. 2022;75:e191&#x2013;e200. doi: 10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;A nationwide cohort study. Eur. J. Pediatr. 2022;184:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326:869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., Bhopal S.S., Hughes R.C., Antonelli M., Murray B., Kl&#xe4;ser K., Kerfoot E., Chen L., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health. 2021;5:708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertran M., Pereira S.M.P., Nugawela M.D., Stephenson T., Shafran R., Ford T., Buszewicz M., Whittaker E., Heyman I., Segal T.Y., et al. The relationship between post COVID symptoms in young people and their parents. J. Infect. 2022;85:702&#x2013;769. doi: 10.1016/j.jinf.2022.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.10.005</ArticleId><ArticleId IdType="pubmed">36216186</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pereira S.M.P., Shafran R., De Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;Mahoney L., Chalder T., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical features and burden of postacute sequelae of SARSCoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176:1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., Ricchiuto A., Sinatti D., Zona M., De Matteis A., D&#x2019;Ilario F., Gentili C., Lanni R., et al. Post-COVID condition in adults and children living in the same household in Italy: A prospective cohort study using the ISARIC global follow-up protocol. Front. Pediatr. 2022;10:834875. doi: 10.3389/fped.2022.834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., Bobkova P., Shikhaleva A., El-Taravi Y., Rumyantsev M., Gamirova A., Bairashevskaia A., Petrova P., et al. COVID Research Team. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Casabianca M., Caula C., Titomanlio L., Lenglart L. Neurological consequences of SARS-CoV-2 infections in the pediatric population. Front. Pediatr. 2023;11:1123348. doi: 10.3389/fped.2023.1123348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2023.1123348</ArticleId><ArticleId IdType="pmc">PMC9973732</ArticleId><ArticleId IdType="pubmed">36865695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingrove J., Makaronidis J., Prados F., Kanber B., Yiannakas M.C., Magee C., Castellazzi G., Grandjean L., Golay X., Tur C., et al. Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: An exploratory, observational study. eClinicalMedicine. 2023;58:101883. doi: 10.1016/j.eclinm.2023.101883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101883</ArticleId><ArticleId IdType="pmc">PMC9980836</ArticleId><ArticleId IdType="pubmed">36883140</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Nugawela M.D., McOwat K., Simmons R., Chalder T., Ford T., Heyman I., Swann O.V., Fox-Smith L., et al. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study. PLoS ONE. 2023;18:e0277704. doi: 10.1371/journal.pone.0277704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0277704</ArticleId><ArticleId IdType="pmc">PMC9987792</ArticleId><ArticleId IdType="pubmed">36877677</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Pata D., McFarland S., Simpson F.K. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: A survey of 510 children. Future Microbiol. 2022;17:577&#x2013;588. doi: 10.2217/fmb-2021-0285.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2021-0285</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemkova S.A. Neurological Aspects of the Sequelae of COVID-19 in Children. Neurosci. Behav. Physiol. 2022;52:1169&#x2013;1176. doi: 10.1007/s11055-023-01344-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11055-023-01344-5</ArticleId><ArticleId IdType="pmc">PMC9930062</ArticleId><ArticleId IdType="pubmed">36817565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., et al. Estimated Global Proportions of Individuals with Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Araf Y., Akter F., Tang Y.D., Fatemi R., Parvez M.S.A., Zheng C., Hossain M.G. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 2022;94:1825&#x2013;1832. doi: 10.1002/jmv.27588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27588</ArticleId><ArticleId IdType="pmc">PMC9015557</ArticleId><ArticleId IdType="pubmed">35023191</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Hong W., Pan X., Lu G., Wei X. SARS-CoV-2 Omicron variant: Characteristics and prevention. MedComm. 2021;2:838&#x2013;845. doi: 10.1002/mco2.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.110</ArticleId><ArticleId IdType="pmc">PMC8693031</ArticleId><ArticleId IdType="pubmed">34957469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh F., Khanizadeh S., Khodadadi H., Mokhayeri Y., Ajorloo M., Malekshahi A., Heydari E. SARS-CoV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study) Microb. Pathog. 2022;168:105595. doi: 10.1016/j.micpath.2022.105595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105595</ArticleId><ArticleId IdType="pmc">PMC9116045</ArticleId><ArticleId IdType="pubmed">35597364</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah S.E., Hao T., DeSantis S.M., Swartz M.D., Talebi Y., Kohl H.W., 3rd, Zhang S., Valerio-Shewmaker M., Yaseen A., Kelder S.H., et al. Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents. Pediatr. Infect. Dis. J. 2022;41:e409&#x2013;e417. doi: 10.1097/INF.0000000000003653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003653</ArticleId><ArticleId IdType="pubmed">35939608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the RealWorld: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H., AlMukdad S., Ayoub H.H., Altarawneh H.N., Coyle P., Tang P., Yassine H.M., Al-Khatib H.A., Smatti M.K., Hasan M.R., et al. COVID-19 Vaccine Protection among Children and Adolescents in Qatar. N. Engl. J. Med. 2022;387:1865&#x2013;1876. doi: 10.1056/NEJMoa2210058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2210058</ArticleId><ArticleId IdType="pmc">PMC9644642</ArticleId><ArticleId IdType="pubmed">36322837</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>